As we begin to reopen Rush University Medical Center for elective procedures and in-person care, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.
Hemophilia A or B Treatment Study
This study will consist of 3 time periods: a screening period of up to 28 days, 1 day of drug administration and 29 days of follow-up.
In order to participate you must meet the following criteria:
- Have moderate to severe hemophilia A or B.
- Are male at least 18 yeras of age.
This is a partial list of elgibility requirements.